M Hukkanen Selected Research

Peptides (Polypeptides)

9/2000

Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Hukkanen Research Topics

Disease

3	Periodontitis 02/2011 - 04/2007
2	Synovitis 03/2009 - 03/2002
2	Inflammation (Inflammations) 10/2008 - 09/2000
2	Bone Resorption 11/2006 - 02/2003
2	Osteoarthritis 01/2005 - 06/2002
2	Necrosis 02/2003 - 01/2003
1	Chronic Periodontitis 02/2011
1	Rheumatoid Arthritis 03/2009
1	Osteomyelitis 11/2006
1	Sialadenitis 01/2005
1	Lymphadenitis (Adenitis) 10/2004
1	Granuloma 11/2003
1	Osteoporosis 02/2003
1	Metabolic Bone Diseases (Osteopenia) 02/2003
1	Ulcerative Colitis 02/2003
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2003
1	Systemic Scleroderma (Systemic Sclerosis) 09/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2002
1	Experimental Arthritis 06/2002
1	Arthritis (Polyarthritis) 03/2002
1	Hyperalgesia 01/2002
1	Pain (Aches) 01/2002
1	Oral Lichen Planus 09/2000
1	Thrombosis (Thrombus) 02/2000

Drug/Important Bio-Agent (IBA)

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 01/2003
3	CytokinesIBA 04/2007 - 02/2003
2	Matrix Metalloproteinases (MMPs)IBA 02/2011 - 04/2007
2	AntigensIBA 11/2003 - 03/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2003 - 01/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2003 - 02/2003
1	CXC ChemokinesIBA 02/2011
1	LipopolysaccharidesIBA 02/2011
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 02/2011
1	Metalloproteases (Metalloproteinases)IBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	DisintegrinsIBA 03/2009
1	Messenger RNA (mRNA)IBA 03/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2008
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2008
1	Interleukin-17 (Interleukin 17)IBA 04/2007
1	Interleukin-1 (Interleukin 1)IBA 04/2007
1	Cysteine (L-Cysteine)FDA Link 11/2006
1	Cathepsin KIBA 11/2006
1	Protein Isoforms (Isoforms)IBA 01/2005
1	Collagen Type II (Type II Collagen)IBA 01/2005
1	Protein Kinase CIBA 10/2004
1	Interleukin-13IBA 11/2003
1	InterleukinsIBA 11/2003
1	NitratesIBA 02/2003
1	Nitroglycerin (Dynamite)FDA LinkGeneric 02/2003
1	Estrogens (Estrogen)FDA Link 02/2003
1	Nitric Oxide DonorsIBA 02/2003
1	Anabolic AgentsIBA 02/2003
1	Interleukin-6 (Interleukin 6)IBA 02/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2003
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2002
1	NeuropeptidesIBA 06/2002
1	radolmidineIBA 01/2002
1	salicylhydroxamic acid (SHAM)IBA 01/2002
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2002
1	Dexmedetomidine FDA Link 01/2002
1	Neuropeptide YIBA 09/2000
1	Calcitonin Gene-Related PeptideIBA 09/2000
1	Peptides (Polypeptides)IBA 09/2000
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 09/2000
1	Substance PIBA 09/2000
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2000
1	Hematoxylin (Haematoxylon)IBA 02/2000

Therapy/Procedure

1	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2002
1	Chemical Sympathectomy 01/2002
1	Ligation 01/2002